In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 4: Chronic Heart Failure – Treatment
Session

Event : Heart Failure 2019

Topic : Other

  • Session type : Poster Session
  • Date : 28 May 2019
  • Time : 08:30 - 12:30

21 presentations in this session

Real life heart failure, a heterogeneous population benefiting from a specialized multidisciplinary programme

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : F Adragao (Cascais,PT)

Factors influencing guideline-led prescribing to heart failure patients in an Egyptian critical care setting

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : S El Hadidi (Cairo,EG)

Meta-analysis on MitraClip implantation for functional mitral regurgitation

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : M Noutsias (Halle (Saale),DE)

Service quality in a heart failure clinic: a comparison analysis to a general cardiology clinic

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : LC Danzmann (Porto Alegre,BR)

Self-care management intervention in heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : S Gerward (Lund,SE)

OPTIMIZE Heart Failure Care Program in Mexico. Impact on early and mid term Heart Failure readmissions

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : J Magana Serrano (Mexico,MX)

Overcoming challenges in adopting guideline-based device therapy in patients with heart failure; a real-world experience

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : A Malaweera (Croydon,GB)

Establishing the first pharmacist-led heart failure medication optimization clinic in the middle east gulf region

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : Z Sadik (Abu Dhabi,AE)

Introduction of a multidisciplinary specialist heart failure team prevented 2 in 3 heart failure readmissions

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : C Plymen (London,GB)

Current status of palliative care for heart failure; from the clinical experience of a general hospital in Japan

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : Y Nishihata (Tokyo,JP)

An evaluation of heart failure register reviews and virtual clinics 2016-2018

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : G Campbell (London,GB)

Non-invasive Venous Waveform Analysis (NIVA) estimates static volume

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : M Polcz (,US)

Vaccination uptake in HF patients; identifying a critical gap of care

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : F Rathore (Lusk Co Dublin,IE)

Multidisciplinary care for end-stage HF. How to improve care?

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : P Fluvia (Girona,ES)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are